A flexible friend

High-net-worth investors have typically had little flexibility to tweak the features of structured product investments. But a new platform launched by UBS gives investors the ability to tailor investments to meet their market views and risk appetites. Clive Davidson reports

pg80-rubberband-gif

Institutional investors have traditionally had the best of the structured products market. These customers have the clout to specify product features and payouts, enabling them to invest in made-to-measure structured products that suit their market view and risk appetite. High-net-worth and retail investors, however, have had to choose their investments off-the-rack. The products are standardised and marketed to tens of thousands of investors over a limited subscription period.

But that's not to

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Chartis RiskTech100® 2024

The latest iteration of the Chartis RiskTech100®, a comprehensive independent study of the world’s major players in risk and compliance technology, is acknowledged as the go-to for clear, accurate analysis of the risk technology marketplace. With its…

T+1: complacency before the storm?

This paper, created by WatersTechnology in association with Gresham Technologies, outlines what the move to T+1 (next-day settlement) of broker/dealer-executed trades in the US and Canadian markets means for buy-side and sell-side firms

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here